Carlo Chiavaroli Selected Research

Calcium Dobesilate

10/2010	Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.
3/2005	Inhibition of choroidal angiogenesis by calcium dobesilate in normal Wistar and diabetic GK rats.
1/2005	Calcium dobesilate in the treatment of diabetic retinopathy.
7/2004	Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlo Chiavaroli Research Topics

Disease

4	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2010 - 07/2004
2	Experimental Melanoma 06/2007 - 07/2005
2	Neoplasms (Cancer) 06/2007 - 12/2006
1	Hypersensitivity (Allergy) 12/2007
1	Pneumonia (Pneumonitis) 12/2007
1	Asthma (Bronchial Asthma) 12/2007
1	Pica (Geophagia) 06/2007
1	Neoplasm Metastasis (Metastasis) 06/2007
1	Hypoxia (Hypoxemia) 12/2006
1	Menorrhagia 05/2006
1	Metrorrhagia (Spotting) 05/2006
1	Hemorrhage 05/2006
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2006
1	Reinfection 01/2006
1	Rheumatoid Arthritis 01/2006
1	Infections 01/2006
1	Urinary Tract Infections (Urinary Tract Infection) 01/2006
1	Spondylarthropathies 01/2006
1	Blindness (Hysterical Blindness) 01/2005
1	Vascular System Injuries 08/2004
1	Ischemia 07/2004
1	Leukemia 01/2004
1	Edema (Dropsy) 04/2003

Drug/Important Bio-Agent (IBA)

4	Calcium DobesilateIBA 10/2010 - 07/2004
3	Ethamsylate (Etamsylate)IBA 05/2006 - 04/2003
3	Hemostatics (Antihemorrhagics)IBA 05/2006 - 04/2003
2	VaccinesIBA 12/2007 - 01/2006
2	OM 197-MP-ACIBA 12/2007 - 01/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2007 - 12/2006
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2007 - 12/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2007 - 07/2005
1	AntigensIBA 12/2007
1	OvalbuminIBA 12/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2007
1	Oxygen (Dioxygen)IBA 12/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2006
1	Interferon-gamma (Interferon, gamma)IBA 12/2006
1	CytokinesIBA 12/2006
1	Protein Isoforms (Isoforms)IBA 12/2006
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 12/2006
1	Radiation-Sensitizing AgentsIBA 12/2006
1	NitritesIBA 12/2006
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2006
1	Pharmaceutical PreparationsIBA 05/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2006
1	Bacterial LysatesIBA 01/2006
1	OM 89IBA 01/2006
1	Protein Kinase C betaIBA 01/2005
1	Aldehyde Reductase (Aldose Reductase)IBA 01/2005
1	CLS 2210IBA 01/2005
1	Streptozocin (Streptozotocin)FDA Link 07/2004
1	AntioxidantsIBA 07/2004
1	Lipid AIBA 01/2004
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2004
1	DipeptidesIBA 01/2004
1	Amino Acids FDA Link 01/2004
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2003
1	Arachidonic Acid (Vitamin F)IBA 04/2003
1	CarrageenanIBA 04/2003

Therapy/Procedure

1	Sublingual Administration 12/2007
1	Drug Therapy (Chemotherapy) 06/2007
1	Contraception (Birth Control) 05/2006
1	Oral Administration 01/2006
1	Glycemic Control 01/2005
1	Laser Therapy (Surgery, Laser) 01/2005